Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RLAY
#1753
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+14.77%
Monthly Change
+21.42%
6 month change
+185.79%
Year Change
+213.76%
Previous Close
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
Volume
219
Markets
US Stock Market
Healthcare
RLAY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Relay Therapeutics stock hits 52-week high at 9.64 USD
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Relay Therapeutics earnings in spotlight after FDA breakthrough
Relay earnings in focus as FDA breakthrough fuels optimism
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
FDA grants breakthrough therapy status to Relay’s breast cancer drug
Relay Therapeutics president sells $166k in RLAY stock
Rahmer Peter, chief corporate development officer at Relay Therapeutics, sells $100k in shares
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism (NASDAQ:RLAY)
Relay Therapeutics stock rises after Oppenheimer upgrade
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns